ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Metal-Ligand Complexes as Multifunctional Platforms for Photo-Activated Cancer Therapy.
Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Coumarin and Curcumin-Metal Complexes as Next-Generation Photosensitizers in Cancer Photodynamic Therapy.International journal of molecular sciences · 2026Review
- Coordination chemistry-enabled drug delivery systems: metal-ligand platforms for controlled release and targeted therapeutics.Journal of nanobiotechnology · 2026Review
- Metal-Ligand Complexes as Multifunctional Platforms for Photo-Activated Cancer Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Metal-ligand complexes have emerged as versatile platforms for photo-activated therapy (PAT) for cancer, including photothermal therapy, photodynamic therapy, and photo-activated chemotherapy. This review explores the unique optical properties and tunable characteristics of these complexes, which enable effective reactive oxygen species generation and near-infrared light absorption for targeted cancer cell destruction. Metal-ligand complexes are classified based on their ligands and metal ions. The ligands include tetrapyrrolic structures, polypyridine, and polyphenols, while the metal ions comprise transition and noble metals. Their individual contributions to enhancing therapeutic efficacy are also explored. Fundamental interactions, including ligand-to-metal charge transfer and metal-ligand coordination, are examined. These interactions significantly influence the photoreactivity and biocompatibility of the complexes. Recent advances integrating metal-ligand complexes with other modalities, such as chemo-phototherapy and immunotherapy, are highlighted. These combinations offer promising approaches for synergistic tumor eradication. The challenges of ligand diversity, delivery optimization, and the underexplored mechanisms in PAT are also discussed. By integrating recent progress and prospective applications, this review emphasizes the critical importance of metal-ligand complexes in innovating cancer theranostic technologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.